A new ileostomy, a stoma made from the small bowel, lets water and salt leave the body faster, and dehydration is the commonest reason for a return to hospital in the first month. In one small, single-hospital randomised trial, a daily rehydration drink for 40 days meant no readmissions for fluid and salt problems, against 24 per cent without it. Guidelines do not yet recommend it for everyone.
The size of the problem. A meta-analysis of 71 studies (82,451 patients) put readmission for dehydration within 30 days of a new ileostomy at 6 per cent, the leading cause among an all-cause readmission rate of 20 per cent.
The trial. In a single-centre randomised trial in Greece, 39 people with a new diverting ileostomy after rectosigmoid resection received an oral isotonic glucose and sodium solution for 40 days after discharge and 41 received no intervention. At 20 days, blood sodium was lower and urea and creatinine higher in the control group. Readmission for fluid and electrolyte abnormalities was 24 per cent in the control group and none in the intervention group (p = 0.001).
The wider evidence. A 2026 scoping review found six eligible studies of oral rehydration solution in adults with an ileostomy who did not have short bowel syndrome or a high-output stoma, of mixed designs, and concluded that standardised, evidence-based regimens are needed.
Where guidelines stand. The ASCRS ostomy guideline (2022) cites the trial within its evidence for ileostomy care pathways, a weak recommendation (2B), and does not recommend the drink on its own.
Shares Toxicity and quality of life are undervalued and the tags protocol-upgrade, upgrade:promising.
Shares Toxicity and quality of life are undervalued and the tags protocol-upgrade, upgrade:promising.
Shares Toxicity and quality of life are undervalued and the tags protocol-upgrade, upgrade:promising.
Shares Toxicity and quality of life are undervalued and the tags protocol-upgrade, upgrade:promising.
Shares Toxicity and quality of life are undervalued and the tags protocol-upgrade, upgrade:promising.
Shares Toxicity and quality of life are undervalued and the tags protocol-upgrade, upgrade:promising.
Shares Toxicity and quality of life are undervalued and the tags protocol-upgrade, upgrade:promising.
Shares Toxicity and quality of life are undervalued and the tags protocol-upgrade, upgrade:promising.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/